Clinical Trial Update: Safety and IOP-Lowering Effects of WB007 [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating safety and intraocular pressure-lowering effects of WB007 in glaucoma and ocular hypertension. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• WB007

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Glaucoma, Primary Open Angle, Ocular Hypertension | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-03-24